Skip to content

Acupuncture and Moxibustion Treatments for the Depression Clinical Trial

Acupuncture and Moxibustion Treatments for the Major Depression Disorder: Randomized, Placebo-controlled Pilot Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0001810
Enrollment
30
Registered
2016-02-11
Start date
2015-12-02
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(acupuncture, electroacupuncture, moxibustion) : A study that compares treatment efficacy of acupuncture, electroacupuncture, moxibustion VS. sham acupuncture, sham electroacupuncture, sham moxi

Sponsors

Korea Institute of Oriental Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. are aged between 19 and 65 years 2. diagnosed first or relapse major depression disorder, are major depression episode within 30days before screening day 3. Hamilton Depression rating scale(HAM-D) scored 7~24 4. agreed with written informed consent

Exclusion criteria

Exclusion criteria: 1. is risk of suicide - scored =2 of No.3 question at Hamilton Depression rating scale(HAM-D) or on scored =midium at Korean suicice risk screening test 2. had serious psychological condition, or can not follow clinical trial because has comunication disorder by mental disorder, mood disorder. 3. pregnant, expecting pregnant or nursing women 4. had serious unstable medical condition by lab study, vital sign 5. had abnormality on lab study with depression (ex. hyperthroidism, hypothyrodism) 6. had separation by death, obviously stress, acute stress reaction - Social Readjustment of Rating Scales scored = 200 7. take exclude therapy within these days a. take all psychotropic within 30 days on screening day(ex. antidepressant, anxiolytic, antipsychotic) b. take non-psychopharmacologocal drugs that have psychotropic effect within 14 days on screening day c. take all psychotherapy within 30 days on screening day d. take electroshock treatment, transcranial magnetic therapy within 30 days on screening day e. take all oriental medical treatment for depression within 14 days on screening day 8. had inflammatory disorder at acupoint 9. had hemorrhagic disease or taking anticoagulant drug 10. had serious head injury, cerebral hemorrhage, cerebral infarction or had another serious physical disease.

Design outcomes

Primary

MeasureTime frame
Hamilton Rating Scale for Depression

Secondary

MeasureTime frame
Beck’s Depression Inventory ;Insomnia Severity Index ;State-Trait Anxiety Inventory;EuroQol-5 dimension ;Measure Yourself Medical Outcome Profile2;Electroencephalogram;Adverse events;Hamilton Rating Scale for Depression

Countries

Korea, Republic of

Contacts

Public ContactJung-Hyo Cho

Daejeon Korean Medicine Hospital of Daejeon University

choajoa@dju.kr+82-42-229-6806

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 11, 2026